Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue
Pixelgen Technologies has raised €26M across 2 funding rounds from 4 investors, most recently a Series B round in Aug 2026. Based in Stockholm, Sweden; active in Healthtech. Data as of 16 Sept 2026.
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-08-20 | Series B | €13M | Flat Capital ,Industrifonden,Navigare Ventures | View deal → |
| 2025-07-01 | Other | €12M | European Innovation Council (EIC) Accelerator | View deal → |
